Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43M Buy
75,278
+10,399
+16% +$201K ﹤0.01% 1828
2025
Q4
$1.06M Sell
64,879
-366,843
-85% -$6.46M ﹤0.01% 1675
2025
Q3
$8.11M Sell
431,722
-239,119
-36% -$4.29M 0.03% 463
2025
Q2
$13.6M Buy
670,841
+127,771
+24% +$2.21M 0.06% 233
2025
Q1
$7.47M Buy
543,070
+251,023
+86% +$3.46M 0.05% 303
2024
Q4
$3.46M Buy
+292,047
New +$4.6M 0.02% 530
2024
Q3
Sell
-424,713
Closed -$7.47M 3248
2024
Q2
$7.47M Sell
424,713
-210,500
-33% -$4.35M 0.04% 292
2024
Q1
$16.3M Sell
635,213
-626,971
-50% -$15.7M 0.1% 96
2023
Q4
$32.9M Buy
+1,262,184
New +$28.8M 0.24% 38
2022
Q2
Sell
-22,745
Closed -$684K 3857
2022
Q1
$684K Buy
+22,745
New +$709K ﹤0.01% 1407

Other funds holding XP

HRT Financial's XP Position: Q1 2026 in Review

HRT Financial increased its XP (XP) stake by 16% in Q1 2026, buying an estimated $201K and bringing the position to 75,278 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1828.

HRT Financial first reported a position in XP in Q1 2022 and has held it in 10 quarters since. The position peaked at $32.9M in Q4 2023. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • HRT Financial held 75,278 shares of XP worth $1.43M as of Q1 2026.
  • HRT Financial bought 10,399 XP shares in Q1 2026, an estimated $201K.
  • XP made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #1828 holding.
  • HRT Financial first reported a position in XP in Q1 2022 and has held it in 10 quarters since.
  • HRT Financial's XP position peaked at $32.9M in Q4 2023.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.